Since the changes of most rebound DEGs/DMPs shared the same directionality in MS and HC, ranging from 60 to 98% in overlap, we continued our analysis on these genes/probes, hereon referred to as shared rebound DEGs/DMPs, comprising a total of 160 and 114 DEGs for CD4+ and CD8+, respectively, and 126 and 2161 DMPs. The gene discussed is CD4; the disease is myeloid sarcoma.